Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study

Abstract Objective The objective of this study was to prospectively evaluate the clinical features of chemotherapy‐induced oral mucositis (CIOM) in adult patients with acute leukemia and the aggravating factors for such symptoms. Subjects Thirty‐seven prospective patients aged ≥19 years with acute l...

Full description

Bibliographic Details
Main Authors: Yeon‐Hee Lee, Junshik Hong, Inho Kim, Youngnim Choi, Hee‐Kyung Park
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Clinical and Experimental Dental Research
Subjects:
Online Access:https://doi.org/10.1002/cre2.253
_version_ 1819081326944321536
author Yeon‐Hee Lee
Junshik Hong
Inho Kim
Youngnim Choi
Hee‐Kyung Park
author_facet Yeon‐Hee Lee
Junshik Hong
Inho Kim
Youngnim Choi
Hee‐Kyung Park
author_sort Yeon‐Hee Lee
collection DOAJ
description Abstract Objective The objective of this study was to prospectively evaluate the clinical features of chemotherapy‐induced oral mucositis (CIOM) in adult patients with acute leukemia and the aggravating factors for such symptoms. Subjects Thirty‐seven prospective patients aged ≥19 years with acute leukemia undergoing chemotherapy were enrolled. Oral and clinical investigations were performed at baseline and on Day 14 after starting chemotherapy. The presence and severity of cancer‐induced oral mucositis were demonstrated using the World Health Organization (WHO) scoring system. Results On Day 14, we found that oral mucositis had developed in eight patients (21.6%). Hematopoietic stem cell transplantation (HSCT) in patients was a predictor of increased WHO scores (β = 1.937, p < .001). Regarding oral sites, ventral tongue (β = 1.670), soft palate (β = 1.242), and buccal mucosa (β = 0.593) were predictors for increased scores. In addition, the increase in WHO scores was positively correlated with the number of oral lesions (r = .521), the difficulty in eating (r = .250), and the overall oral health (r = .534; all p < .05). Conclusion The main factors affecting the severity of CIOM symptoms were the treatment with HSCT and the location of oral lesions. The incidence of CIOM and WHO scores were not significantly different between the subgroups of disease. Our findings will help clinicians investigate the oral findings after chemotherapy in adult patients with acute leukemia.
first_indexed 2024-12-21T19:59:00Z
format Article
id doaj.art-606f82d14a7e49169c1ca2ab7b945b45
institution Directory Open Access Journal
issn 2057-4347
language English
last_indexed 2024-12-21T19:59:00Z
publishDate 2020-02-01
publisher Wiley
record_format Article
series Clinical and Experimental Dental Research
spelling doaj.art-606f82d14a7e49169c1ca2ab7b945b452022-12-21T18:52:01ZengWileyClinical and Experimental Dental Research2057-43472020-02-0161909910.1002/cre2.253Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary studyYeon‐Hee Lee0Junshik Hong1Inho Kim2Youngnim Choi3Hee‐Kyung Park4Department of Orofacial Pain and Oral Medicine Kyung Hee University Dental Hospital Seoul KoreaDepartment of Internal Medicine Seoul National University Hospital, Seoul National University College of Medicine Seoul KoreaDepartment of Internal Medicine Seoul National University Hospital, Seoul National University College of Medicine Seoul KoreaDepartment of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute Seoul National University Seoul KoreaDepartment of Oral Medicine and Oral Diagnosis, Dental Research Institute Seoul National University Dental Hospital, Seoul National University School of Dentistry Seoul KoreaAbstract Objective The objective of this study was to prospectively evaluate the clinical features of chemotherapy‐induced oral mucositis (CIOM) in adult patients with acute leukemia and the aggravating factors for such symptoms. Subjects Thirty‐seven prospective patients aged ≥19 years with acute leukemia undergoing chemotherapy were enrolled. Oral and clinical investigations were performed at baseline and on Day 14 after starting chemotherapy. The presence and severity of cancer‐induced oral mucositis were demonstrated using the World Health Organization (WHO) scoring system. Results On Day 14, we found that oral mucositis had developed in eight patients (21.6%). Hematopoietic stem cell transplantation (HSCT) in patients was a predictor of increased WHO scores (β = 1.937, p < .001). Regarding oral sites, ventral tongue (β = 1.670), soft palate (β = 1.242), and buccal mucosa (β = 0.593) were predictors for increased scores. In addition, the increase in WHO scores was positively correlated with the number of oral lesions (r = .521), the difficulty in eating (r = .250), and the overall oral health (r = .534; all p < .05). Conclusion The main factors affecting the severity of CIOM symptoms were the treatment with HSCT and the location of oral lesions. The incidence of CIOM and WHO scores were not significantly different between the subgroups of disease. Our findings will help clinicians investigate the oral findings after chemotherapy in adult patients with acute leukemia.https://doi.org/10.1002/cre2.253adultschemotherapy‐induced oral mucositis (CIOM)hematopoietic stem cell transplantation (HSCT)leukemiaWHO score
spellingShingle Yeon‐Hee Lee
Junshik Hong
Inho Kim
Youngnim Choi
Hee‐Kyung Park
Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
Clinical and Experimental Dental Research
adults
chemotherapy‐induced oral mucositis (CIOM)
hematopoietic stem cell transplantation (HSCT)
leukemia
WHO score
title Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
title_full Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
title_fullStr Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
title_full_unstemmed Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
title_short Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
title_sort prospective evaluation of clinical symptoms of chemotherapy induced oral mucositis in adult patients with acute leukemia a preliminary study
topic adults
chemotherapy‐induced oral mucositis (CIOM)
hematopoietic stem cell transplantation (HSCT)
leukemia
WHO score
url https://doi.org/10.1002/cre2.253
work_keys_str_mv AT yeonheelee prospectiveevaluationofclinicalsymptomsofchemotherapyinducedoralmucositisinadultpatientswithacuteleukemiaapreliminarystudy
AT junshikhong prospectiveevaluationofclinicalsymptomsofchemotherapyinducedoralmucositisinadultpatientswithacuteleukemiaapreliminarystudy
AT inhokim prospectiveevaluationofclinicalsymptomsofchemotherapyinducedoralmucositisinadultpatientswithacuteleukemiaapreliminarystudy
AT youngnimchoi prospectiveevaluationofclinicalsymptomsofchemotherapyinducedoralmucositisinadultpatientswithacuteleukemiaapreliminarystudy
AT heekyungpark prospectiveevaluationofclinicalsymptomsofchemotherapyinducedoralmucositisinadultpatientswithacuteleukemiaapreliminarystudy